30
July
Highly attenuated β-herpesvirus with potent immunomodulatory capacity as vaccine vector against SARS-CoV-2
Project title: Highly attenuated β-herpesvirus with potent immunomodulatory capacity as vaccine vector against SARS-CoV-2
Grantor: Croatian Science Foundation
Grantor’s website: www.hrzz.hr
Coordinator: Prof. Dr. Astrid Krmpotic
Research team:
Asst. Prof. Dr. Irena Slavuljica
Dr. Maja Cokaric Brdovcak
Dr. Lea Hirsl
Mijo Golemac, dr. med.
Tina Jenus, mag. biotech. in med.
Marko Sustic, dr. med.
Mihaela Kordun, dipl. ing. mol.
Total funding: EUR 197.200,00
Brief description:
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), appeared in China at the end of 2019 and has rapidly increased into global pandemic and a major public health issue. COVID-19 symptoms can range from very